Meridian™
Universe

PCRX · CIK 0001396814 · FY2025 live · 2025-12-31

Pacira BioSciences, Inc.

DistressSEC 10-KClassic ZHealthcare72nd percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

1.54

Zone

Distress

Prior

—

Market DD

—

1y PD

—

1.54

Z″ 3.08

−21.83.08+

Score 1.54 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.34
    1.2 × = 0.41

  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    −0.16
    1.4 × = −0.22

  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    0.02
    3.3 × = 0.05

  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    1.21
    0.6 × = 0.73

  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.57
    1 × = 0.57

Five-year path

Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.

Overview

rule-v1

Pacira BioSciences, Inc. is on classic Z at 1.54 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print; sales / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.

Book screen Distress; market PD —. Tape not priced — not a single default call.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 72nd percentile in Healthcare.

KPI widgets

Current assets

$548M

Total assets

$1.3B

Current liabilities

$121M

Total liabilities

$572M

Working capital

$427M

Retained earnings

−$199M

EBIT

$19M

Total sales

$726M

Book equity

$693M

Accession 0001628280-26-012297. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.